A SMART Map for 3D printing in biomedicine
As well as for the Precision medicine and Synbio, also for 3D printing in biomedicine, the first draft of SMART Map has been produced and released. The document is the result of the two events held in Munich and in Milan, aiming at performing an inclusive process of co-design, involving representatives from relevant industries, research institutions, healthcare, the public sector, civil society, and patients’ organisations.
Angela Simone from Giannino Bassetti Foundation organized the second Dialogue on this topic. Here she highlights one of the key messages that have been implemented in the SMART Map.
“The comparison between the different European industrial settings has been crucial to get a broad and deep overview on how the field has developed so far. New comers (SMEs and start-ups) and hybrid actors such as makerspaces and FabLabs play an increasingly relevant role in this innovation landscape. For this, rules and regulations should take into account the needs of these important actors which, as we have learned from them, are definitely keen to include RRI elements in their innovation pipelines”, commented Ralf Lindner, leader of the tasks of the project devoted to 3Dmed sector.
Click here to download the SMART Map
Additive Bio-Manufacturing in Europe
The Science and Technology Impact Assessment Panel of the European Parliament has conducted a foresight study on “Additive bio-manufacturing: 3D printing for medical recovery and human enhancement“. The project aims to assess 3D printing of biological or conventional materials for the purpose of rehabilitating, supporting or augmenting biological functionality, and will be used to examine potential policy needs in the area.
Here is one of the main outcomes of the study
In regulating medical products and services, legislators are called upon to balance the need for high standards and responsible processes against the greater financial and technical barriers that these present to innovators in the sector. Higher costs can create challenges in ensuring equitable access to cutting-edge medical treatments. DIY 3D-bioprinting activities that occur outside professional laboratories are difficult to monitor and regulate, but could pose safety and security threats, and may even infringe principles of medical ethics.